Opportunity Overview
Georgia CORE / Georgia Center for Oncology Research and Education is accepting proposals for the All Together Stop Cancer Supplemental Award, funded through the All Together Stop Cancer specialty license plate. The program supports cancer education, screening, and access to treatment across Georgia, with the 2026 supplemental cycle emphasizing education and screening initiatives for colorectal, lung, and prostate cancers.
Funding
Georgia CORE will award two supplemental grants of $10,000 each. The applicant-relevant maximum is $10,000, and total stated funding for this cycle is $20,000.
Eligibility and Geography
Applicants must be 501(c)(3) nonprofit organizations in Georgia. The opportunity is statewide. Breast cancer is excluded from this award because it is supported separately through Georgia’s Breast Cancer license plate program. Other cancer types may be considered when supported by community epidemiological need.
Deadline and Award Period
The RFP was released August 24, 2026. Proposals are due September 25, 2026. The controlling public notice does not publish a submission time or time zone, so Atlas does not infer one. Awards are expected to be announced in October 2026. The award period is December 1, 2026 through November 30, 2027.
Program Scope and Costs
The published notice states that funds are intended to support cancer education and screening initiatives, with particular emphasis on colorectal, lung, and prostate cancers, while the broader program supports education, screening, and access to treatment. The public notice does not provide a complete eligible/ineligible-cost schedule, procurement or vendor rules, match or cost-share requirements, registration requirements, required forms or attachments, qualification or reference requirements, or amendment/FAQ terms. Those items must be confirmed in the Georgia CORE application portal before final submission.
Submission and Contact
Applications are submitted through Georgia CORE’s online application portal. Program contact: Katreena Davis, MPH, kdavis@georgiacore.org. No solicitation or funding number is stated on the controlling public notice.
Atlas Analysis
Atlas Opportunity Score: 94/100. This is a focused, currently open Georgia cancer-health opportunity with direct statewide nonprofit eligibility and a clear 2026 funding cycle.
N9+ Fit Score: 20/100, low and conditional. The Nonagon N9+ should not be treated as a colorectal, lung, or prostate cancer screening modality. A limited ancillary role in telehealth-enabled clinical encounters or navigation may be conceivable only if the applicant’s program design and Georgia CORE’s cost rules support it. Atlas will not force N9+ into this opportunity. QC Healthcare fit: unverified/low.
Georgia Priority Applicant
East Georgia Cancer Coalition is a strong prospective applicant. It is a Georgia 501(c)(3) regional cancer nonprofit serving 53 East Georgia counties and operates cancer education, prevention, early-detection, screening, and navigation activities, including colorectal screening work. Atlas Organization Opportunity Score: 98/100. Any application should be built around the coalition’s documented current program needs and the final portal requirements.
Direct-Vendor Review
Dr. Miltie, LLC is not an eligible direct applicant because the applicant must be a Georgia 501(c)(3) nonprofit. A Dr. Miltie or QC Healthcare role would be limited to a legitimate vendor or project-partner relationship if the applicant chooses it and Georgia CORE confirms the proposed cost is allowable.
Controlling Source
Georgia CORE / Georgia Cancer Info – 2026 All Together Stop Cancer proposal notice. Atlas verified September 21, 2026.